J. Saarela

Differential drug sensitivity score (DSS) for indolent and aggressive prostate cancer cell lines

S. Timonen, J. Bernoulli, P. Östling, 2016 .

Suppression of BRCA1 sensitizes cells to proteasome inhibitors

J. Jonkers, D. Greco, Y. Gu, 2014, Cell Death and Disease.

BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine

J. Martens, A. Sokolenko, E. Imyanitov, 2016, Scientific Reports.

Prediction of drug combination effects with a minimal set of experiments

T. Aittokallio, K. Wennerberg, A. Giri, 2019, Nature Machine Intelligence.

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

David T. W. Jones, T. Holland-Letz, F. Westermann, 2022, npj Precision Oncology.

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data

T. Aittokallio, K. Wennerberg, B. Seashore-Ludlow, 2023, Nucleic Acids Res..

Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling

C. Heckman, M. Mirzaie, Mohieddin Jafari, 2023, bioRxiv.

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.

L. Paavolainen, V. Pietiäinen, O. Kallioniemi, 2024, Antiviral research.

Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.

M. Mendiola, S. Potdar, J. Pozo-Kreilinger, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.